SOPHiA GENETICS (SOPH) Cash from Financing Activities (2020 - 2025)

SOPHiA GENETICS has disclosed Cash from Financing Activities across 6 years of filings, most recently posting -$385000.0 for Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at -$385000.0, up 67.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $30.2 million (up 206.15% YoY), and the FY2025 annual result was $30.2 million, up 206.15% from the prior year.
• Cash from Financing Activities came in at -$385000.0 for Q4 2025 at SOPHiA GENETICS, up from -$2.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $237.7 million in Q3 2021 to a low of -$2.0 million in Q3 2025.
• The 5-year median for Cash from Financing Activities is -$599500.0 (2022), against an average of $13.7 million.
• Across the five-year window, Cash from Financing Activities plunged 366.81% in 2023 and surged 2187.56% in 2024, its largest moves.
• SOPHiA GENETICS's Cash from Financing Activities stood at -$447000.0 in 2021, then retreated by 29.75% to -$580000.0 in 2022, then climbed by 11.72% to -$512000.0 in 2023, then sank by 128.12% to -$1.2 million in 2024, then jumped by 67.04% to -$385000.0 in 2025.
• The last three Cash from Financing Activities figures came in at -$385000.0 (Q4 2025), -$2.0 million (Q3 2025), and $33.5 million (Q2 2025), per Business Quant data.